Medication info
Widerset Tablets

Widerset Tablets

Prescription medicationTabletOral
Ingredient · strength
Acetaminophen›325mg / 1 tabletTramadol Hydrochloride›37.5mg / 1 tablet
Manufacturer / importer
Widurs Pharmaceuticals Co., Ltd.
Appearance
Pale yellow, rectangular film-coated tablets
Packaging
30 tablets/bottle, 300 tablets/bottle, 100 tablets (10 tablets/PTP x 10)/box [for export]
Approval status
Active

MFDS item code 200805152 · Notified 2008.05.06 · Insurance code 660702150

Summary

Main use
Relief of moderate to severe acute and chronic pain
Who takes it
Adults · Children
Adult dose
Adults: The dose should be adjusted according to the patient's level of pain and response to treatment. An initial dose of 2 tablets is recommended. Thereafter, leave an interval of at least 6 hours between doses and do not exceed 8 tablets per day. Use the lowest effective dose for the shortest possible duration. Do not use this drug for longer than necessary. If long-term treatment is required due to the nature and severity of the disease, conduct regular monitoring to determine whether treatment with this drug should continue. Elderly Administer the usual adult dose. However, since the elimination half-life of tramadol increased by 17% when tramadol was administered orally to elderly patients aged 75 years or older, administer this drug at intervals of at least 6 hours. Patients with renal impairment For patients with moderate renal impairment (creatinine clearance 10-30ml/min), extend the dosing interval to 12 hours. Administration is not recommended for patients with severe renal impairment (creatinine clearance less than 10ml/min). Since tramadol is removed very slowly by hemodialysis and filtration, there is no need to readminister this drug after dialysis to maintain the analgesic effect. Patients with hepatic impairment Carefully consider extending the dosing interval in patients with moderate hepatic impairment. Do not administer this drug to patients with severe hepatic impairment.
Child dose
Children aged 12 years and older: The dose should be adjusted according to the patient's level of pain and response to treatment. An initial dose of 2 tablets is recommended. Thereafter, leave an interval of at least 6 hours between doses and do not exceed 8 tablets per day. Use the lowest effective dose for the shortest possible duration. Do not use this drug for longer than necessary. If long-term treatment is required due to the nature and severity of the disease, conduct regular monitoring to determine whether treatment with this drug should continue.

Ingredients

Manufacturer
Widurs Pharmaceuticals Co., Ltd.

Efficacy & effects

Relief of moderate to severe acute and chronic pain

  • Moderate to severe acute pain
  • chronic pain
View approved original text

This medication is used to relieve moderate to severe acute and chronic pain.

How to take

Adult dose

Adults: The dose should be adjusted according to the patient's level of pain and response to treatment. An initial dose of 2 tablets is recommended. Thereafter, leave an interval of at least 6 hours between doses and do not exceed 8 tablets per day. Use the lowest effective dose for the shortest possible duration. Do not use this drug for longer than necessary. If long-term treatment is required due to the nature and severity of the disease, conduct regular monitoring to determine whether treatment with this drug should continue. Elderly Administer the usual adult dose. However, since the elimination half-life of tramadol increased by 17% when tramadol was administered orally to elderly patients aged 75 years or older, administer this drug at intervals of at least 6 hours. Patients with renal impairment For patients with moderate renal impairment (creatinine clearance 10-30ml/min), extend the dosing interval to 12 hours. Administration is not recommended for patients with severe renal impairment (creatinine clearance less than 10ml/min). Since tramadol is removed very slowly by hemodialysis and filtration, there is no need to readminister this drug after dialysis to maintain the analgesic effect. Patients with hepatic impairment Carefully consider extending the dosing interval in patients with moderate hepatic impairment. Do not administer this drug to patients with severe hepatic impairment.

Child dose

Children aged 12 years and older: The dose should be adjusted according to the patient's level of pain and response to treatment. An initial dose of 2 tablets is recommended. Thereafter, leave an interval of at least 6 hours between doses and do not exceed 8 tablets per day. Use the lowest effective dose for the shortest possible duration. Do not use this drug for longer than necessary. If long-term treatment is required due to the nature and severity of the disease, conduct regular monitoring to determine whether treatment with this drug should continue.

Precautions

This drug may put strain on the liver, so individuals who consume more than three glasses of alcohol daily should consult a doctor or pharmacist before use. This medication may rarely cause serious skin reactions, and if skin rash or allergic symptoms occur after taking it, discontinue use immediately and consult a healthcare professional. Due to the risk of seizures, do not exceed the recommended dosage, and the possibility of seizures may increase when taken with certain antidepressants or narcotic pain relievers. Rarely, severe allergic reactions may occur; if symptoms such as difficulty breathing or hives appear, seek emergency treatment immediately. Patients with severe respiratory diseases may experience significant respiratory suppression while taking this medication, hence it should only be used in a monitored healthcare setting. Caution is needed when combining this drug with alcohol or central nervous system depressants, as severe drowsiness, respiratory suppression, and coma may occur. Patients with head injuries or increased intracranial pressure should use this medication cautiously, as symptoms may worsen. This drug can cause physical and psychological dependence, so it should be taken following a doctor's instructions for extended periods. Patients with impaired liver function must consult a doctor before taking this medication, as there is a risk of liver damage. Those with genetic characteristics that lead to very rapid metabolism of this drug are at increased risk of respiratory suppression and require special attention. This drug should not be administered to children under 12 years old or adolescents under 18 years old following certain surgeries. Patients with sleep apnea or hypoxemia should continuously monitor for symptom exacerbation while using this medication. Elderly patients or those at risk of hyponatremia should be closely observed for symptoms of low sodium during treatment. Pregnant or breastfeeding women should consult thoroughly with a doctor before using this medication, as it may pose risks to the fetus or newborn. Caution is advised as drowsiness or dizziness may occur while driving or operating machinery. Overdose may result in severe respiratory depression, seizures, liver damage, etc., so strictly adhere to the recommended dosage and seek medical attention immediately if unusual symptoms arise.

Side effects

Liver damage, acute generalized exanthematous pustulosis, Stevens-Johnson syndrome, toxic epidermal necrolysis, seizures, anaphylactic reactions, respiratory depression, deep sedation, coma, death, loss of appetite, insomnia, depression, dizziness, headache, drowsiness, nausea, vomiting, constipation, dry mouth, diarrhea, dyspepsia, abdominal pain, abdominal discomfort, flatulence, pruritus, sweating, rash, fatigue, flushing, urticaria, hypersensitivity, hypoglycemia, anxiety, irritability, emotional instability, euphoria, decreased libido, sleep disorders, confusion, disorientation, agitation, abnormal dreams, drug abuse, hallucinations, withdrawal syndrome, migraine, somnolence, sensory loss, tremor, paresthesia, attention deficit, syncope, memory impairment, psychomotor agitation, sedation, amnesia, perceptual disturbance, convulsions, blurred vision, visual impairment, miosis, dizziness, tinnitus, ear discomfort, palpitations, tachycardia, hypertension, hypotension, dyspnea, dry throat, elevated liver enzymes, generalized pruritus, diaphoresis, urination disorders, erectile dysfunction, asthenia, chest pain, abnormal emotions, chills, chest discomfort, lethargy, drug withdrawal syndrome, thirst, irritability, warmth sensation, weight loss, increased serum creatinine, anaphylactic reactions, unstable emotions, delirium, suicidal ideation, muscular hypertonicity, movement disorders, serotonin syndrome, speech disorders, mydriasis, orthostatic hypotension, hepatitis, gait disturbances, prolonged prothrombin time, thrombocytopenia, agranulocytosis, blood disorders, hyponatremia, fixed rash, asthenia, fever, edema, rigidity, syncope, congestive heart failure, vertigo, confusion, aggravated migraine, involuntary muscle contraction, dyspnea, asthma, exercise-induced dyspnea, cough, bronchitis, urinary retention, frequent urination, abnormal kidney function values, oliguria, increased sweating, dysphagia, tongue swelling, increased salivation, progression of rectal cancer, progression of esophageal cancer, progression of gastric cancer, paralytic ileus, hiccups, cholecystitis, dissociation, anemia, decreased hemoglobin, decreased red blood cells, increased white blood cells, decreased white blood cells, thrombocytopenia, arrhythmia, aggravated hypertension, aortic stenosis, hemorrhage, elevated cholesterol, tinnitus, hip pain, thigh pain, allergic rhinitis, nasal hemorrhage, abnormal vision, progression of biliary tract cancer, foreign body sensation in the eye, progression of liver cancer, liver dysfunction, nausea, dizziness, seizures, myocardial infarction, QT prolongation, abdominal discomfort, lethargy, pallor, hyperhidrosis, anxiety, sweating, rigidity, pain, tremor, upper respiratory syndrome, lip tremors, agitation, irritability, hyperactivity, panic attacks, severe anxiety, hallucinations, perceptual disturbances, tinnitus, abnormal central nervous system responses, urticaria, bronchospasm, toxic skin necrosis, opioid-induced hyperalgesia, symptoms of acute or chronic adrenal insufficiency (severe abdominal pain, nausea, vomiting, hypotension, extreme fatigue, loss of appetite, weight loss)

Not everyone experiences these, and they can vary from person to person.

Storage

Store this medication in a sealed container to prevent air or moisture ingress. The recommended storage temperature is room temperature between 1 to 30 degrees Celsius.

Appearance and packaging

Appearance

Pale yellow, rectangular film-coated tablets

Package unit

30 tablets/bottle, 300 tablets/bottle, 100 tablets (10 tablets/PTP x 10)/box [for export]

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.